Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.05M Buy
17,195
+7,818
+83% +$2.79M 0.19% 102
2025
Q4
$3.07M Buy
9,377
+2,537
+37% +$805K 0.09% 172
2025
Q3
$1.93M Buy
6,840
+529
+8% +$153K 0.06% 212
2025
Q2
$1.76M Sell
6,311
-394
-6% -$112K 0.07% 206
2025
Q1
$2.09M Buy
6,705
+1,343
+25% +$397K 0.1% 160
2024
Q4
$1.4M Sell
5,362
-26
-0.5% -$7.71K 0.07% 204
2024
Q3
$1.74M Buy
5,388
+217
+4% +$71K 0.11% 154
2024
Q2
$1.62M Buy
5,171
+1,435
+38% +$422K 0.12% 139
2024
Q1
$1.06M Buy
3,736
+1,999
+115% +$585K 0.1% 177
2023
Q4
$500K Buy
+1,737
New +$473K 0.07% 270

Other funds holding AMGN

Atomi Financial Group's AMGN Position: Q1 2026 in Review

Atomi Financial Group increased its Amgen (AMGN) stake by 83% in Q1 2026, buying an estimated $2.79M and bringing the position to 17,195 shares worth $6.05M. The position accounts for 0.19% of the portfolio, ranked #102.

Atomi Financial Group first reported a position in AMGN in Q4 2023 and has held it in 10 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Atomi Financial Group held 17,195 shares of Amgen worth $6.05M as of Q1 2026.
  • Atomi Financial Group bought 7,818 Amgen shares in Q1 2026, an estimated $2.79M.
  • Amgen made up 0.19% of Atomi Financial Group's portfolio in Q1 2026, its #102 holding.
  • Atomi Financial Group first reported a position in Amgen in Q4 2023 and has held it in 10 quarters since.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Atomi Financial Group's 13F filing for Q1 2026, filed 14 May 2026.